Charles Bennett to Thalidomide
This is a "connection" page, showing publications Charles Bennett has written about Thalidomide.
Connection Strength
1.810
-
Thalidomide, Drug Safety, and Off-label Prescribing: Lessons Learned From Celgene's Settlement. JAMA Oncol. 2018 07 01; 4(7):915-916.
Score: 0.583
-
Underreporting of hemorrhagic and thrombotic complications of pharmaceuticals to the U.S. Food and Drug Administration: empirical findings for warfarin, clopidogrel, ticlopidine, and thalidomide from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. 2012 Nov; 38(8):905-7.
Score: 0.393
-
A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report. J Oncol Pract. 2012 Nov; 8(6):e158-67.
Score: 0.388
-
Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer. JAMA. 2006 Dec 06; 296(21):2558-60.
Score: 0.261
-
Systemic Barriers and Potential Concerns from Reporting Serious Adverse Drug Reactions. Cancer Treat Res. 2022; 184:75-85.
Score: 0.186